Windtree Therapeutics Inc (WINT)

$0.14 +0.03 (24.55%)
Market Cap 1.77M
Revenue (ttm) 0.00
Net Income (ttm) -1.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.05
Volume 6,696,000
Avg Vol 12,863,387
Day's Range N/A - N/A
Shares Out 3.66M
Stochastic %K 10%
Beta 0.63
Analysts Strong Buy
Price Target $4.00

Company Profile

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infan...

Industry: Biotechnology
Sector: Healthcare
Phone: 215 488 9300
Address:
2600 Kelly Road, Suite 100, Warrington, United States
Mike827
Mike827 Dec. 25 at 4:03 AM
$WINT is now load time?🤷🏿‍♀️
0 · Reply
Mike827
Mike827 Dec. 24 at 4:14 PM
$WINT now what 🤷🏿‍♀️
0 · Reply
Mike827
Mike827 Dec. 24 at 2:25 PM
$WINT do they have any drugs anymore?
0 · Reply
JohnTrack
JohnTrack Dec. 23 at 6:39 PM
$WINT watching for a trigger!!
0 · Reply
JohnTrack
JohnTrack Dec. 23 at 4:44 PM
$WINT Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates https://www.rapidticker.com/news/wint-windtree-therapeutics-announces-the-sale-c7b521
0 · Reply
Sarandon
Sarandon Dec. 23 at 2:10 PM
$WINT Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates Dec 23, 2025 Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues) Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000 Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings
0 · Reply
WaveRider666
WaveRider666 Dec. 22 at 1:14 PM
$WINT - PPS hasn't touched the Daily EMA 50 since July, 2025. PPS hasn't touched the Daily EMA 100 since August, 2024. Massive toxic dilution in the last year. CEO is failing miserably. Reverse Split, death spiral and bankruptcy coming soon if CEO and management doesn't pull their head out of their own azzes.
1 · Reply
Mahdinur
Mahdinur Dec. 19 at 2:16 AM
$WINT absolutely What do they think by saying they'll buy Binance? Are they clinical trial or crypto currency store? Thats why i opted for $GRI with a real disesse to treat
1 · Reply
Mike827
Mike827 Dec. 17 at 7:43 PM
$WINT management here is complete idiots
0 · Reply
Sarandon
Sarandon Dec. 3 at 2:08 PM
$WINT Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space Dec 03, 2025 https://ir.windtreetx.com/news-releases/news-release-details/windtree-therapeutics-announces-it-has-signed-letter-intent
0 · Reply
Latest News on WINT
No data available.
Mike827
Mike827 Dec. 25 at 4:03 AM
$WINT is now load time?🤷🏿‍♀️
0 · Reply
Mike827
Mike827 Dec. 24 at 4:14 PM
$WINT now what 🤷🏿‍♀️
0 · Reply
Mike827
Mike827 Dec. 24 at 2:25 PM
$WINT do they have any drugs anymore?
0 · Reply
JohnTrack
JohnTrack Dec. 23 at 6:39 PM
$WINT watching for a trigger!!
0 · Reply
JohnTrack
JohnTrack Dec. 23 at 4:44 PM
$WINT Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates https://www.rapidticker.com/news/wint-windtree-therapeutics-announces-the-sale-c7b521
0 · Reply
Sarandon
Sarandon Dec. 23 at 2:10 PM
$WINT Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates Dec 23, 2025 Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues) Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000 Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings
0 · Reply
WaveRider666
WaveRider666 Dec. 22 at 1:14 PM
$WINT - PPS hasn't touched the Daily EMA 50 since July, 2025. PPS hasn't touched the Daily EMA 100 since August, 2024. Massive toxic dilution in the last year. CEO is failing miserably. Reverse Split, death spiral and bankruptcy coming soon if CEO and management doesn't pull their head out of their own azzes.
1 · Reply
Mahdinur
Mahdinur Dec. 19 at 2:16 AM
$WINT absolutely What do they think by saying they'll buy Binance? Are they clinical trial or crypto currency store? Thats why i opted for $GRI with a real disesse to treat
1 · Reply
Mike827
Mike827 Dec. 17 at 7:43 PM
$WINT management here is complete idiots
0 · Reply
Sarandon
Sarandon Dec. 3 at 2:08 PM
$WINT Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space Dec 03, 2025 https://ir.windtreetx.com/news-releases/news-release-details/windtree-therapeutics-announces-it-has-signed-letter-intent
0 · Reply
Mahdinur
Mahdinur Dec. 3 at 1:29 AM
$WINT dead with their bnb $GRI primed for action
0 · Reply
ScamDiscovery
ScamDiscovery Dec. 2 at 2:59 PM
$WINT Be sure and contact Jed Latkin to congratulate him on his first full year as CEO. Accomplishments: 1. Lost 99.8% of investors' money. 2. Failed crypto treasury. 3. Failed environmental deal. 4. Failed Houston property deal. 5. But he continues his $550,000 salary. Just so you know, your shares are worthless and will be worth zero in the next 30 days. Take a hard look at the paper, you don't own anything, Seven Knots is in control here. And guess what else? The Istaroximine is not good enough data for ANY company out there to spend money on it? It is worthless now. This guy continues his toxic dilutive BS for ONE PURPOSE ONLY: To get his big check every month. Copy and paste and email this post to [email protected]
1 · Reply
azazelhazel
azazelhazel Dec. 2 at 2:03 PM
$PAVS $PRPH $OONEF $WINT
0 · Reply
WaveRider666
WaveRider666 Dec. 1 at 7:44 PM
$WINT - PPS hasn't touched the Weekly EMA 20 since mid 2024 and PPS hasn't touched the Weekly EMA 50 since early 2021. As the toxic dilution increased, the gap between the PPS and the EMA 50 increased. Corporations lose all credibility as a legitimate business when this happens.
1 · Reply
mcrotary
mcrotary Nov. 24 at 2:58 PM
$WINT grabbed some
1 · Reply
WaveRider666
WaveRider666 Nov. 20 at 12:45 PM
$WINT
0 · Reply
Pedrogs87
Pedrogs87 Nov. 19 at 6:41 PM
$WINT Need it good news... https://bucksco.today/2025/11/windtree-therapeutics-titan-environmental-services/
0 · Reply
WaveRider666
WaveRider666 Nov. 19 at 6:12 PM
$WINT - Toxic dilution SCAM. CEO is just going to keep financially raping retail traders until there's none left to rape. When's the R/S ???
1 · Reply
YorkMeister
YorkMeister Nov. 19 at 3:53 PM
$WINT my coffee shops were worth more than this company, and I have a small investment here ?!🤣
0 · Reply
Sarandon
Sarandon Nov. 17 at 2:06 PM
$WINT Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee Nov 17, 2025 https://ir.windtreetx.com/news-releases/news-release-details/windtree-therapeutics-announces-it-may-receive-license-agreement
0 · Reply
Stock_Catcher
Stock_Catcher Nov. 17 at 2:00 PM
$WINT Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
0 · Reply
abjosh
abjosh Nov. 14 at 2:14 PM
$WINT lol for a drug that does not meet primary endpoint, no big pharma interests and all they do is apply for patents lol Fuvked up management that has lied consistently to shareholders just to enrich their pockets.
1 · Reply